Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.63 |
| ▸ | TSHR | P16473 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | GLA | P06280 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.59 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.58 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.57 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.57 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.56 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.55 |
| ▸ | TUBB | P07437 | 1/20 | 0.55 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.55 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.55 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.55 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.55 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.55 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.55 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.55 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17046502 | 1.00 | TAAR1 (0.63) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL3245187 | 0.98 | TAAR1 (0.65) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL3239644 | 0.93 | TAAR1 (0.67) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL9762628 | 0.93 | TAAR1 (0.55) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL21402276 | 0.92 | TAAR1 (0.58) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL18454017 | 0.91 | HTR1A (0.64) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL21402284 | 0.91 | TAAR1 (0.59) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL9281549 | 0.90 | TAAR1 (0.76) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL10763724 | 0.86 | TAAR1 (0.71) | TAAR1TSHRMAPK1LMNAGLA | |
| SCHEMBL5072123 | 0.86 | TAAR1 (0.76) | TAAR1TSHRMAPK1LMNAGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114588246-A | Balanced metabolism formula | 上海慕韩斋健康管理咨询有限公司 | 2022-06-07 | — | — | CN | claimed |
| CN-113143838-A | Light compact shaping product and preparation method thereof | 广东丽姿生物科技有限公司 | 2021-07-23 | — | — | CN | claimed |
| EP-1517880-B1 | PRODUCTION OF CIS-PELLITORIN AND USE AS A FLAVOURING | SYMRISE AG (DE) | 2011-01-05 | — | — | EP | claimed |
| EP-1896557-B1 | FLAVOR AND FRAGRANCE COMPOSITION | TAKASAGO PERFUMERY CO LTD (JP) | 2010-05-05 | — | — | EP | claimed |
| US-20090275669-A1 | Flavor and fragrance composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-11-05 | — | — | US | claimed |
| EP-1896557-A1 | FLAVOR AND FRAGRANCE COMPOSITION | Takasago International Corporation (JP) | 2008-03-12 | — | — | EP | claimed |
| WO-2006137556-A1 | FLAVOR AND FRAGRANCE COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-12-28 | — | — | WO | claimed |
| EP-1167435-B1 | Inclusion compounds of vanillyl alcohol derivative in cyclodextrin and compositions containing the same | TAKASAGO PERFUMERY CO LTD (JP) | 2004-12-01 | — | — | EP | claimed |
| US-20040086476-A1 | Anti-dandruff and anti-itch compositions containing sensate and sensate enhancer-containing compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2004-05-06 | — | — | US | claimed |
| US-20030161802-A1 | Anti-dandruff and anti-itch compositions containing sensate and sensate enhancer-containing compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2003-08-28 | — | — | US | claimed |
| CN-1436520-A | Antiscurf and antiitch composition containing sensory agent and sensory intensifier compound | INT FLAVORS & FRAGRANCES INC (US) | 2003-08-20 | — | — | CN | claimed |
| EP-1332772-A2 | Anti-dandruff and anti-itch compositions containing a cooling sensate material and a cooling sensate enhancer | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2003-08-06 | — | — | EP | claimed |
| US-6570010-B2 | Comprises a cyclodextrin or a branched cyclodextrin and a vanillyl alcohol derivative, such as vanillyl-n butyl ether | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2003-05-27 | — | — | US | claimed |
| US-20020013235-A1 | Inclusion compounds of vanillyl alcohol derivative in cyclodextrin and compositions containing the same | TAKASAGO INTERNATIONAL CORPORATION | 2002-01-31 | — | — | US | claimed |
| EP-1167435-A2 | Inclusion compounds of vanillyl alcohol derivative in cyclodextrin and compositions containing the same | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | claimed |
| CN-122031449-A | External pharmaceutical composition containing loxoprofen and diclofenac | 第一三共健康事业株式会社 | 2026-05-15 | — | — | CN | disclosed |
| CN-122031446-A | External pharmaceutical composition containing loxoprofen and felbinac | 第一三共健康事业株式会社 | 2026-05-15 | — | — | CN | disclosed |
| EP-1186289-A2 | Method and agent for enhancing diffusivity and long-lasting property of fragrance. | Takasago International Corporation (JP) | 2002-03-13 | — | — | EP | disclosed |
| US-20020013235-A1 | Inclusion compounds of vanillyl alcohol derivative in cyclodextrin and compositions containing the same | TAKASAGO INTERNATIONAL CORPORATION | 2002-01-31 | — | — | US | disclosed |
| EP-1167435-A2 | Inclusion compounds of vanillyl alcohol derivative in cyclodextrin and compositions containing the same | Takasago International Corporation (JP) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275669-A1 | Flavor and fragrance composition | TAS2R40, TAS2R1, TAS2R50 | TAAR1 471/4885TSHR 3954/4885MAPK1 848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.